The LSH-TA Project is funded under the National Complementary Plan (NCP) to the NRRP - National Recovery and Resilience Plan, promoted by the Italian Ministry of Health within the investment “Innovative Health Ecosystem” (NCP-E.3).

The project is coordinated by the Bambino Gesù Children's Hospital, acting as the Hub, and is structured as a national research innovation ecosystem aimed at strengthening collaborations among scientific, healthcare, and industrial institutions.

The G. d’Annunzio University Chieti-Pescara (Ud’A) participates in the project as a Tier 2 Spoke.

LSH-TA aims to enhance and develop infrastructures and expertise in the field of Advanced Therapy Medicinal Products (ATMPs), which include gene therapies, cell therapies, and tissue-engineered products, representing the frontier of personalised and precision medicine.

Ud’A Scientific Coordinator: Prof. Di Mauro Ianni

Ud’A Departments involved:

• Department of Pharmacy 
• Department of Medicine and Ageing Sciences 
• Department of Neuroscience, Imaging and Clinical Sciences 
• Department of Medical, Oral and Biotechnological Sciences 
• Department of Innovative Technologies in Medicine & Dentistry 

Ud’A Budget: €5,000,000.00 (€2,500,000.00 funding + €2,500,000.00 co-funding)
Total Project Budget: €70,145,879.00